Year: 2026
Type: article
Abstract: CRISPR-based diagnostics have evolved from proof-of-concept nucleic acid assays to increasingly integrated platforms for streamlined canonical/non-canonical single or multiplex target detection with digital quantification. Here we review these advances according to their ability to regulate Cas activity and dissect key checkpoints of CRISPR activation. We also organize advanced CRISPR-based diagnostic systems by their use of four regulatory dimensions: activation-threshold control, reaction compatibility and temporal coordination, spatial organization, and catalytic signal transduction. This framework reveals common mechanisms and limitations underlying current engineering strategies and provides a conceptual foundation for predictable, standardizable, and clinically translatable Cas activity engineering.
Source: ACS Sensors
Authors: Zhen Huang, Christopher J. Lyon, Tony Y. Hu
Institutions: Tulane University, Tsinghua University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
Awards: G2320146047, Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management, CRISPR-TB for pediatric TB diagnosis and treatment response, Rapid Detection of TB from Blood using Cell-Free DNA and CRISPR, CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary disease, Multiplexed detection of cell-free M. Tuberculosis DNA and its drug-resistant variants in blood, Mtb and HIV/SIV antigen peptide signatures as blood biomarkers to detect early infection to active disease in young children and NHP, Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
OpenAlex ID: W7236584617
